- A Whopper of an honor: Local company named top Burger King franchisee (11/15/17)3
- Southern Illinois farmer's grapevines destroyed by dicamba; four years of work lost (10/29/17)2
- Aldi store reopens after renovations (11/14/17)3
- Residents view pedestrian bridge as eyesore; city manager says it's designed to rust (11/13/17)8
- Decisions coming soon on steel mill, smelter in New Madrid (11/17/17)1
- Federal jury finds surgeon Fonn guilty of kickback scheme (11/10/17)4
- State audit: Bollinger County tax levies violate state law; county commission disagrees (11/17/17)3
- Cape native co-directs Thanksgiving-related indie film, 'Drinksgiving' (11/17/17)
- Son of Westboro Baptist Church patriarch discusses abuse, faith (11/15/17)6
- Scott City council hires former SEMO public safety director as city administrator (11/15/17)
Protein gives clue to Parkinson's
WASHINGTON -- A protein that exists normally in most of the cells in the brain has been identified as a possible factor in the development of Parkinson's disease -- a finding that could point the way to treatments but raise questions about current therapy.
In lab experiments, when the brain protein alpha-synuclein combines with dopamine in nerve cells it can trigger the production of toxic reactive oxygen molecules that kill the nerves, according to a research team led by Dr. Bruce A. Yankner of Harvard.
If this process operates in patients the same way it does in the laboratory, it could set scientists on the path to potential treatments, Yankner said.
But it also adds to the debate over whether the current use of dopamine in the treatment of Parkinson's could make things worse in the long run, he added.
The findings appear in the June issue of the journal Nature Medicine.
Dr. Ronald Lee Hamilton of the University of Pittsburgh called the research "a significant advance, but not a major breakthrough."
"It does not address the question of why alpha-synuclein accumulates in these neurons, but it does provide a potential mechanism by which these neurons might die," he said.
'Adds to information'
Dr. Robert E. Burke of Columbia University said the study "adds to the growing body of information which is pointing toward the importance of synuclein's role in affecting the viability of dopamine neurons."
Neither Hamilton nor Burke was connected with the research team.
More than a million Americans are victims of Parkinson's, which causes muscle stiffness and tremor as neurons in the brain are damaged. The disease has received widespread attention due to several prominent patients, including former Attorney General Janet Reno, boxing champion Muhammad Ali and actor Michael J. Fox.
Alpha-synuclein is present in most cells in the brain and its normal function is not entirely clear, Yankner said in a telephone interview. It may have a protective function against stresses, he said.
In Parkinson's disease there are lesions on the nerve cells that turn out to be made of alpha-synuclein and other chemicals,, he said. In addition, some families with a mutated form of alpha-synuclein have a tendency to develop Parkinson's.